Back

Learner’s Digest International (TM)

  • Biosimilar Pharmaceuticals
  • Inflammatory Bowel Diseases

Is There Anyone Still Afraid of Biosimilars?

The goal of this program is to improve the management of inflammatory bowel disease using biosimilars. After hearing and assimilating this program, the clinician will be better able to: 1. Define biosimilars and elucidate key concerns associated with their use. 2. Integrate biosimilars into clinical practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Nov 22, 2027 1 year left